Διαχείριση της Αναιμίας

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Πηγή‎: Crit Care 2005;9(5):R508-15.

Καταχώριση‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (ανοίγει νέο παράθυρο)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (ανοίγει νέο παράθυρο)

Hong T, Shander A, Agarwal S, Castresana M.

Πηγή‎: A A Case Rep 2015;4(10):127-31.

Καταχώριση‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (ανοίγει νέο παράθυρο)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (ανοίγει νέο παράθυρο)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Πηγή‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Καταχώριση‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (ανοίγει νέο παράθυρο)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (ανοίγει νέο παράθυρο)

Lindholm J, Palmér K, Frenckner B.

Πηγή‎: Perfusion 2012;27(4):332-4.

Καταχώριση‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (ανοίγει νέο παράθυρο)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (ανοίγει νέο παράθυρο)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Πηγή‎: Am Surg 2010;76(9):951-6.

Καταχώριση‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (ανοίγει νέο παράθυρο)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (ανοίγει νέο παράθυρο)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Πηγή‎: Intensive Care Med 2013;39(11):1896-908.

Καταχώριση‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (ανοίγει νέο παράθυρο)

Transfusion-free treatment strategies for acute anemia in critical care. (ανοίγει νέο παράθυρο)

Morgan CA, Byul Sarah S, Forest CP.

Πηγή‎: JAAPA 2016;29(8):38-44.

Καταχώριση‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (ανοίγει νέο παράθυρο)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (ανοίγει νέο παράθυρο)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Πηγή‎: J Trauma 2008;65(2):285-97.

Καταχώριση‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (ανοίγει νέο παράθυρο)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (ανοίγει νέο παράθυρο)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Πηγή‎: J Trauma 2009;67(1):121-4.

Καταχώριση‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (ανοίγει νέο παράθυρο)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (ανοίγει νέο παράθυρο)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Πηγή‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Καταχώριση‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (ανοίγει νέο παράθυρο)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (ανοίγει νέο παράθυρο)

Posluszny JA Jr, Napolitano LM.

Πηγή‎: Transfusion 2014;54(12):3026-34.

Καταχώριση‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (ανοίγει νέο παράθυρο)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (ανοίγει νέο παράθυρο)

Price S, Pepper JR, Jaggar SI.

Πηγή‎: Anesth Analg 2005;101(2):325-7.

Καταχώριση‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (ανοίγει νέο παράθυρο)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (ανοίγει νέο παράθυρο)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Πηγή‎: Am Surg 2015;81(6):e263-5.

Καταχώριση‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (ανοίγει νέο παράθυρο)

Erythropoietin response is blunted in critically ill patients. (ανοίγει νέο παράθυρο)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Πηγή‎: Intensive Care Med 1997;23(2):159-62.

Καταχώριση‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (ανοίγει νέο παράθυρο)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (ανοίγει νέο παράθυρο)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Πηγή‎: Br J Anaesth 2005;94(4):442-4.

Καταχώριση‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (ανοίγει νέο παράθυρο)

Management of anemia in patients who decline blood transfusion. (ανοίγει νέο παράθυρο)

Shander A, Goodnough LT

Πηγή‎: Am J Hematol 2018;93(9):1183-91.

Καταχώριση‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (ανοίγει νέο παράθυρο)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (ανοίγει νέο παράθυρο)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Πηγή‎: Arch Surg 2012;147(3):251-5.

Καταχώριση‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (ανοίγει νέο παράθυρο)

Intravenous iron following cardiac surgery does not increase the infection rate. (ανοίγει νέο παράθυρο)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Πηγή‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Καταχώριση‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (ανοίγει νέο παράθυρο)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (ανοίγει νέο παράθυρο)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Πηγή‎: Crit Care 2015;19:49.

Καταχώριση‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (ανοίγει νέο παράθυρο)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (ανοίγει νέο παράθυρο)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Πηγή‎: Crit Care Med 2024;52(4):618-25.

Καταχώριση‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (ανοίγει νέο παράθυρο)

ΕΠΕΊΓΟΥΣΑ ΚΑΙ ΕΝΤΑΤΙΚΉ ΘΕΡΑΠΕΊΑ

Διαχείριση της Αναιμίας

Ελληνική

Διαχείριση της Αναιμίας

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (ανοίγει νέο παράθυρο)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (ανοίγει νέο παράθυρο)

Reducing postburn injury anemia in a Jehovah's Witness patient. (ανοίγει νέο παράθυρο)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (ανοίγει νέο παράθυρο)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (ανοίγει νέο παράθυρο)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (ανοίγει νέο παράθυρο)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (ανοίγει νέο παράθυρο)

Erythropoietin for critically ill trauma patients: a missed opportunity? (ανοίγει νέο παράθυρο)

Postoperative management of severe acute anemia in a Jehovah's Witness. (ανοίγει νέο παράθυρο)

Restrictive transfusion in geriatric trauma patients. (ανοίγει νέο παράθυρο)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (ανοίγει νέο παράθυρο)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (ανοίγει νέο παράθυρο)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (ανοίγει νέο παράθυρο)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (ανοίγει νέο παράθυρο)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (ανοίγει νέο παράθυρο)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (ανοίγει νέο παράθυρο)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (ανοίγει νέο παράθυρο)

Transfusion-free treatment strategies for acute anemia in critical care. (ανοίγει νέο παράθυρο)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (ανοίγει νέο παράθυρο)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (ανοίγει νέο παράθυρο)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (ανοίγει νέο παράθυρο)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (ανοίγει νέο παράθυρο)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (ανοίγει νέο παράθυρο)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (ανοίγει νέο παράθυρο)

Erythropoietin response is blunted in critically ill patients. (ανοίγει νέο παράθυρο)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (ανοίγει νέο παράθυρο)

Management of anemia in patients who decline blood transfusion. (ανοίγει νέο παράθυρο)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (ανοίγει νέο παράθυρο)

Intravenous iron following cardiac surgery does not increase the infection rate. (ανοίγει νέο παράθυρο)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (ανοίγει νέο παράθυρο)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (ανοίγει νέο παράθυρο)

Επικοινωνία με Τοπικό Εκπρόσωπο της Επιτροπής Προσέγγισης Νοσοκομείων

Ενημερωτικό Υλικό για τον Ιατρικό Κλάδο

Βίντεο

Διαχείριση της Αναιμίας

Επιλέξτε τη Γλώσσα Σας

Κοινή χρήση